Bacteria in the human gut rarely update their CRISPR defense systems
A new study of the microbiome finds intestinal bacterial interact much less often with viruses that trigger immunity updates than bacteria in the lab.
A new study of the microbiome finds intestinal bacterial interact much less often with viruses that trigger immunity updates than bacteria in the lab.
Inviting recent postdocs and sabbatical-eligible faculty to pursue their research at MIT, new programs envision eventually supporting 16 Israeli scholars on campus annually.
Five MIT faculty and staff, along with five alumni, are honored for electrical engineering and computer science advances.
Junior Katie Spivakovsky describes her path through New Engineering Education Transformation to biomedical research and beyond.
Ten objects on display in the Koch Institute Public Galleries offer uncommon insights into the people and progress of MIT's cancer research community.
Using high-powered lasers, this new method could help biologists study the body’s immune responses and develop new medicines.
By sidestepping the need for costly interventions, a new method could potentially reveal gene regulatory programs, paving the way for targeted treatments.
The drug-device combination developed by MIT spinout Lumicell is poised to reduce repeat surgeries and ensure more complete tumor removal.
MIT engineers’ new model could help researchers glean insights from genomic data and other huge datasets.
The combination of phototherapy and chemotherapy could offer a more effective way to fight aggressive tumors.
SMART researchers find mesenchymal stromal cells are an attractive alternative to current costly, time-intensive treatments.
Labs that can’t afford expensive super-resolution microscopes could use a new expansion technique to image nanoscale structures inside cells.
A research scientist and internationally recognized authority in the field of blood cell development reflects on 45 years at MIT.
MIT’s innovation and entrepreneurship system helps launch water, food, and ag startups with social and economic benefits.
MIT researchers find that the first dose primes the immune system, helping it to generate a strong response to the second dose, a week later.